Navigation Links
OncoSec Medical Announces $7.2 Million Public Offering
Date:12/13/2012

SAN DIEGO, Dec. 13, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced today that it has entered into definitive agreements with institutional investors to purchase approximately $7.2 million of securities in a registered public offering. OncoSec has agreed to sell to institutional investors an aggregate of 28,800,000 shares of its common stock at $0.25 per share. Additionally, investors will receive warrants to purchase up to 14,400,000 shares of common stock at an exercise price of $0.26 per share for a term of four years.

(Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)

The gross proceeds of the offering are expected to be approximately $7.2 million. Net proceeds, after deducting the placement agent's fee and other estimated offering expenses payable by OncoSec, are expected to be approximately $6.5 million.

OncoSec intends to use proceeds from the offering for general corporate purposes, including clinical trial expenses and research and development expenses.

Dawson James Securities, Inc. acted as the exclusive placement agent for the transaction.  Burrill LLC and Noble Financial Capital Markets acted as financial advisors to OncoSec in connection with the transaction.

The offering is expected to close on December 17, 2012, subject to customary closing conditions.

The securities described above are being offered by OncoSec pursuant to a registration statement previously filed and declared effective by the Securities and Exchange Commission, or the SEC. A prospectus supplement related to the offering will be filed with the SEC. The securities may only be offered by means of a prospectus. Copies of the prospectus and prospectus supplement can be obtained directly from OncoSec and at the
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
6. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
7. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
8. OncoSec Granted New Patent from China
9. OncoSec to Present at Upcoming Healthcare and Investor Conferences
10. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
11. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... March 31, 2015   Unique Pharmaceuticals , a ... complete and the company has initiated sterile compounding operations ... goal as a company is to meet and exceed ... . "Meeting the new regulations is validation of our ... the future of our industry, investing in its continued ...
(Date:3/31/2015)... DUBLIN , Mar. 27, 2015 Research ... announced the addition of the "European Laboratory ... Information System), by Type (Clinical Pathology Laboratory Information ... to 2019" report to their offering. ... estimated to grow at a CAGR of 7.6% ...
(Date:3/31/2015)... 27, 2015 Research and Markets ... the "North American Laboratory Information System (LIS) ... Type (Clinical Pathology Laboratory Information System, Anatomic Pathology ... report to their offering. The North ... grow at a CAGR of 7.8% from 2014 ...
Breaking Medicine Technology:Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 2European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 3North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 3
... ASTRO Booth #825 -- Tuesday, October 4 ... Oncology,s (ASTRO) 53rd Annual Meeting, at the Miami Beach Convention ... Foundation with a check. The company,s activities at ASTRO raised ... to contributing the proceeds from ticket sales for the Elekta ...
... Oct. 4, 2011 Qmed.com , the world,s ... search engine, and central industry resource, today revealed its ... and streamlined navigation is based on user research ... and continuous analysis over the past 16 months. ...
Cached Medicine Technology:Media Alert: Elekta to Present $50,000 to Miami-Based Sandy B. Muller Breast Cancer Foundation at ASTRO Annual Meeting 2Leading Medical Device Industry Resource Qmed Reveals Significant Enhancements Based on User-Driven Feedback 2Leading Medical Device Industry Resource Qmed Reveals Significant Enhancements Based on User-Driven Feedback 3
(Date:3/31/2015)... Scotch Plains, NJ (PRWEB) March 31, 2015 ... a board certified dermatologist by the American Board ... surgeon. After extensive dermatology research training at the ... Health, Dr. Li completed his internship in internal ... at the University of Pennsylvania in Philadelphia. Dr. ...
(Date:3/31/2015)... Healthpointe’s team of hip ... their clinics. Specialties include hip dislocations, fractures, bursitis, sprains/strains, ... with hip injuries, Healthpointe has a renowned team of ... symptoms and underlying causes of the hip pain. Doctors ... future damage, while taking into consideration the patient’s athletic ...
(Date:3/31/2015)... One of the most beautiful and awe-inspiring aspects ... Kilauea on the big island. The big island of Hawaii, ... see molten lava slowly oozing at your feet in one of ... One place you would never expect to see a live volcano ... Mission, Texas -- until now. , Members of a local and ...
(Date:3/31/2015)... 31, 2015 National Adaptive Sports ... and psychological benefits of participating in adaptive sports ... adaptive sports athletes that adapt, believe and compete ... for inclusive fitness and inclusive athletics in our ... in adaptive sports and advocate for an increase ...
(Date:3/31/2015)... March 31, 2015 With intravenous (IV) ... using a catheter. Patients, typically, are prescribed IV infusion ... oral medications are no longer effective. Illness often ... to help with electrolyte imbalances. Infusion therapy benefits ... In addition to treating dehydration, IV infusion therapy can ...
Breaking Medicine News(10 mins):Health News:Dr. Andrew Li of Warren Skin Care Center Is Celebrating 3 Years Recognized as an "NJ Top Doc" 2Health News:Healthpointe Now Treating Hip Dislocations, Hip Fractures, Hip Bursitis, and Hip Strains at Locations in Southern California 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 3Health News:April is National Adaptive Sports Month 2Health News:April is National Adaptive Sports Month 3Health News:Intravenous Infusion Therapy Now Available at Urgent Care of Texas Centers; Hospital-Level Care in an Outpatient Setting. 2
... High Court, would ensure that patients or their relatives would ... on demand. Until now, patients and family members have been ... the doctor or hospital as they tend to treat it ... that it is their property and therefore refuse to give ...
... to govern child ads for junk foods. This media regulator ... launching// a 10-week consultation on guidelines restricting the adverts. ... said children should not be encouraged to eat too many ... research indicates TV adverts have a "modest direct effect" on ...
... have revealed that hospitals are raking in huge amounts courtesy ... reports that trusts had made up to ?1.5 million a ... which earned the maximum revenue, were large ones with a ... that University Hospital Birmingham made ?1.5 million from car parking ...
... the leading cause of maternal death are hemorrhage and ... ,Statistics show that about 8 million women ... every year. Dr A. Meting Gulmezoglu, of the WHO's ... was the leading cause of maternal deaths in Africa ...
... who postpone their motherhood and get their first pregnancy ... a research//. ,Older women could be more vulnerable ... reduced capacity to handle the stress of pregnancy, said ... ,Researchers led by Andra James studied 12 million ...
... have found a reason as why bird flu transmissions among humans ... of affecting cells// in the nose and windpipe. When a ... air. But scientist says that this might change as and when ... does not give any guarantee about the virus and it can ...
Cached Medicine News:Health News:Charging Car Park Fees From Cancer Patients Is Morally Wrong, Says Macmillan Cancer Relief 2
Portless Sheath Introducers...
Introducer Sheath Designed for Vascular Access...
Used to introduce balloon, electrode, closed or non-tapered end and,other catheters....
... Driver Stent design, utilizing an ... limitations of stainless steel stents. ... thinner struts, for unparalleled flexibility ... Driver Coronary Stent Systemwith thin ...
Medicine Products: